Solid organ transplantation provides life-saving and life-enhancing treatments for patients with end-stage organ failure.1,2 However, the rising global burden of non-communicable diseases (NCDs) and ...

Over the past decade, several novel immunotherapies have transformed the treatment landscape of relapsed or refractory B-cell acute lymphoblastic leukaemia. In the pivotal TOWER trial, blinatumomab—a ...